UK experts will speed up work on cannabisBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7141.1333d (Published 02 May 1998) Cite this as: BMJ 1998;316:1333
- John Warden, parliamentary correspondent
Research into the clinical use of cannabinoids is to be put on to a new basis in Britain with the formation of a committee of experts who will draw up guidelines for good practice. The working party on the therapeutic uses of cannabinoids is being set up by the Royal Pharmaceutical Society of Great Britain and will be headed by Sir William Asscher, a former chairman of the government Committee on Safety of Medicines.
The aim is that the guidelines will encourage the Home Office to approve research licences which are currently being delayed. The development was reported by BMA …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial